TB-500 10MG is a research-use-only peptide designed for laboratory studies. This molecule is a modified form of the human thymosin beta-4 protein, offering potential exploration in cellular regeneration research contexts. For research use only.
$55.00
RESEARCH USE ONLY
This product is for R&D purposes only and is not approved for human or veterinary use.
Orders placed Monday-Friday will be shipped the next business day (Excludes Holidays)
Trusted third-party testing ensures each batch’s purity and compliance with regulations.
This product is solely intended for research purposes as a chemical compound. Its designation permits its use exclusively for in vitro testing and laboratory experimentation. All information regarding this product provided on our website is purely educational. By law, any form of bodily introduction of this product into humans or animals is strictly prohibited. It should only be handled by professionals who are licensed and qualified. This product is neither a drug, food, nor cosmetic and must not be misrepresented, misused, or mislabelled as such.
TB-500 10MG
TB-500 is a synthetic peptide composed of the first five amino acids of the human bone morphogenetic protein 3 (BMP-3). Originally developed as a research tool in cell biology, TB-500 has been investigated for its potential effects on cellular repair and regeneration in vitro and in animal models. This peptide is provided exclusively for research purposes under strict adherence to laboratory protocols.
Research Context
TB-500 has emerged as a subject of interest in preclinical studies examining its role in tissue regeneration, wound healing, and cellular proliferation. Unlike its naturally occurring precursor BMP-3, TB-500 retains a portion of the bioactive sequence that is known to influence signaling pathways involved in extracellular matrix synthesis and cytoskeletal organization. Early findings in cell culture models suggest its potential utility in studying mechanisms of tissue repair, though direct clinical applications remain speculative and beyond its designated research scope.
Research Overview
TB-500 was first synthesized to investigate the molecular determinants of BMP signaling. Over time, studies have explored its effects on:
Protein kinase C (PKC) activation and signaling cascades
Extracellular matrix deposition in fibroblast cultures
Collagen and elastin synthesis in dermal models
While these studies have provided foundational insights into peptide biology, the peptide itself has not been evaluated for therapeutic efficacy in humans or animals. This information is intended for academic and industrial research applications only.
Key Research Focus Areas
Cellular Proliferation Studies: TB-500 has been assessed in vitro for its capacity to enhance fibroblast proliferation and matrix secretion, particularly in contexts where tissue repair is required.
Wound Healing Models: Animal studies have explored its potential to accelerate epithelialization and collagen deposition in excisional or burn wound models, though variability in results exists across different research paradigms.
Signal Transduction Mechanisms: Mechanistic investigations have centered on its interaction with transforming growth factor-beta (TGF-β) receptors and downstream Smad signaling pathways.
Skeletal Tissue Applications: In preclinical orthopedic research, TB-500 has been evaluated for its effects on osteoblast activity and bone matrix formation, though results have not yet translated to clinical bone repair strategies.
It is important to note that TB-500’s effects are highly dependent on dosage, delivery method, and biological context. Research findings are published under peer-reviewed journals and are subject to ongoing refinement based on emerging data. For research institutions utilizing this material, compliance with institutional biosafety protocols is mandatory.
For research use only. Not for human or animal consumption.
Reviews
There are no reviews yet.